These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6420961)

  • 1. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 2. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of OX40 gene expression in graft-versus-host disease.
    Miura Y; Thoburn CJ; Bright EC; Arai S; Hess AD
    Transplant Proc; 2005; 37(1):57-61. PubMed ID: 15808546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allorecognition and graft-versus-host disease.
    Theobald M
    Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T4+ cells can initiate human graft-versus-host disease.
    Atkinson K; Cooley M; Farrelly H; O'Flaherty E; Concannon A; Dodds A; Biggs J
    Transplant Proc; 1987 Apr; 19(2):2879-81. PubMed ID: 3105126
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions.
    Truitt RL; Ash RC
    Prog Clin Biol Res; 1987; 244():409-21. PubMed ID: 3310003
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
    Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
    Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
    Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
    Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
    Hess AD; Vogelsang GB; Heyd J; Beschorner WE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2683-6. PubMed ID: 3547947
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies.
    Forman SJ; Zaia JA; Wright C; Gallagher MT; Blume KG
    Transplantation; 1986 Feb; 41(2):268-71. PubMed ID: 3003978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppression and the problems in homologous bone marrow transplantation].
    Yabe H; Kato S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune reconstitution post-bone marrow transplantation.
    Gelfand EW
    Int J Cell Cloning; 1986; 4 Suppl 1():19-25. PubMed ID: 3528331
    [No Abstract]   [Full Text] [Related]  

  • 17. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
    Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell depletion of human bone marrow for allogeneic marrow transplantation.
    Farrelly H; Cooley M; O'Flaherty E; Biggs J; Atkinson K
    Transplant Proc; 1987 Apr; 19(2):2855-7. PubMed ID: 3551227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.